We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STML
276
DELISTED
Stemline Therapeutics, Inc.
STML
| $34.1M | 0.08% |
3,210,000
-1,190,000
| -27% | -$11.8M |
|
|
FISV
277
Fiserv Inc
FISV
$28.8B
| $34.1M | 0.08% |
294,810
-243,600
| -45% | -$26.9M |
|
|
JBTM
278
JBT Marel
JBTM
$7.21B
| $33.8M | 0.08% |
+300,000
| New | +$32.1M |
|
279
T. Rowe Price
TROW
$23.9B
| $33.2M | 0.08% |
272,130
-27,900
| -9% | -$3.29M |
|
|
EIGR
280
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $33.2M | 0.08% |
74,167
| – | – |
|
281
AutoZone
AZO
$49.2B
| $33.1M | 0.08% |
27,815
-2,000
| -7% | -$2.31M |
|
|
ORBC
282
DELISTED
ORBCOMM, Inc.
ORBC
| $32.7M | 0.08% |
7,762,551
-200,000
| -3% | -$855K |
|
283
Emerson Electric
EMR
$83.9B
| $32.6M | 0.08% |
426,901
+116,300
| +37% | +$8.38M |
|
284
IQVIA
IQV
$38.7B
| $32.5M | 0.08% |
210,600
-10,000
| -5% | -$1.46M |
|
|
WWE
285
DELISTED
World Wrestling Entertainment
WWE
| $32.4M | 0.08% |
500,000
+225,000
| +82% | +$14.2M |
|
286
Dollar General
DG
$28B
| $32.3M | 0.08% |
207,077
-14,100
| -6% | -$2.24M |
|
287
TransDigm Group
TDG
$70.2B
| $32.1M | 0.08% |
57,352
+5,511
| +11% | +$3.02M |
|
|
FLG
288
Flagstar Bank National Association
FLG
$5.93B
| $32.1M | 0.08% |
890,000
+96,472
| +12% | +$3.56M |
|
289
Eversource Energy
ES
$26.9B
| $31.9M | 0.08% |
375,500
-17,900
| -5% | -$1.49M |
|
290
Tyson Foods
TSN
$20.4B
| $30.9M | 0.08% |
339,655
-46,300
| -12% | -$3.98M |
|
291
Agilent Technologies
A
$39.1B
| $30.6M | 0.08% |
358,518
-23,514
| -6% | -$1.85M |
|
292
Synchrony
SYF
$24.7B
| $30.2M | 0.07% |
838,112
-503,426
| -38% | -$18M |
|
293
Skyworks Solutions
SWKS
$9.37B
| $30M | 0.07% |
248,250
+75,600
| +44% | +$7.43M |
|
|
PPL
294
PPL Corp
PPL
$26.5B
| $29.9M | 0.07% |
833,900
-40,000
| -5% | -$1.34M |
|
295
O'Reilly Automotive
ORLY
$72.9B
| $29.9M | 0.07% |
1,023,000
-385,500
| -27% | -$11M |
|
296
Centene
CNC
$30.7B
| $29.9M | 0.07% |
475,172
-22,900
| -5% | -$1.24M |
|
297
Vertiv
VRT
$93B
| $29.8M | 0.07% |
+2,700,000
| New | +$28.2M |
|
298
Southwest Airlines
LUV
$22B
| $29.8M | 0.07% |
551,677
-40,200
| -7% | -$2.23M |
|
299
Archer Daniels Midland
ADM
$38.2B
| $29.7M | 0.07% |
640,392
-30,800
| -5% | -$1.31M |
|
300
McKesson
MCK
$100B
| $29.6M | 0.07% |
214,060
-14,600
| -6% | -$2.06M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.